SARS-CoV-2 Nucleocapsid Antibody, monoclonal
![Recombinant-SARS-CoV-2 (COVID-19) RBD Neutralizing Antibody [S2E12]](https://www.axilscientific.com/87025-small_default/recombinant-sars-cov-2-covid-19-rbd-neutralizing-antibody-s2e12-.jpg)
Brand:
11-589
- Brand
- ProSci
- Specificity
- This product can recognize SARS-CoV-2 and SARS-CoV Nucleocapsid protein. No cross-reactivity is detected with nucleocapsid protein of other coronaviruses, including MERS-CoV, HCoV-229E, HCoV-NL63, HCoV-OC43 and HCoV-HKU1.
- Clonality
- Recombinant Monoclonal
- Isotype
- Human IgG1/kappa
- Concentration
- Batch dependent
- Immunogen
- Anti-SARS-CoV-2 Nucleocapsid Antibody, Human IgG1 is isolated from a SARS-CoV-2 infected patient and is recombinantly produced from human 293 cells (HEK293).
- Buffer
- Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 . Normally trehalose is added as protectant before lyophilization.
- Application Note
- This antibody can be paired with other Anti-SARS-CoV-2 Nucleocapsid antibodies to detect SARS-CoV-2 Nucleocapsid protein in sandwich ELISA or LFA assay.
- Storage
- For long term storage, the product should be stored at lyophilized state at -20˚C or lower..Please avoid repeated freeze-thaw cycles.This product is stable after storage at:.-20 to -70˚C for 12 months in lyophilized state from date of receipt;.-70˚C for 3 months under sterile conditions after reconstitution.
- Tested Applications
- E
WB
- Conjugate
- Unconjugated
- Physical State
- Lyophilized
- Species Reactivity
- Human
Related products
